BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma

NCT04318327 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
96
Enrollment
INDUSTRY
Sponsor class

Stopped Business decision

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals